Lista de obras - Pawel Surowiak - Dominio Público Uruguay

A comprehensive overview of targeted therapy in metastatic renal cell carcinoma

artículo científico publicado en 2012

ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome

artículo científico publicado en 2006

ABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome

artículo científico publicado en 2011

Analysis of estrogen receptor (ER) and estrogen-dependent pS2 protein expression in cells of mammary ductal carcinoma

scientific article published on 01 January 2001

Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients

scientific article published on 01 December 2008

Analysis of the expression of estrogen and progesteron receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle.

artículo científico publicado en 2001

Application of Microarrays for the Prediction of Therapy Response in Breast Cancer

scientific article published on 01 September 2005

Application of biotinylated tyramine to amplify reactions with horseradish peroxidase labelling

scientific article published on 01 January 1999

Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up.

artículo científico publicado en 2016

Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients

artículo científico publicado en 2005

Betulinic acid exhibits stronger cytotoxic activity on the normal melanocyte NHEM-neo cell line than on drug-resistant and drug-sensitive MeWo melanoma cell lines.

artículo científico publicado en 2009

Biomarkers for systemic therapy in ovarian cancer

artículo científico publicado en 2014

CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases

scientific article published on 01 January 2006

CD46 Expression is an unfavorable prognostic factor in breast cancer cases

artículo científico publicado en 2011

CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients

artículo científico publicado en 2006

COX-2 expression pattern is related to ovarian cancer differentiation and prognosis, but is not consistent with new model of pathogenesis

artículo científico publicado en 2014

Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines.

artículo científico publicado en 2009

Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells.

artículo científico

Computational analysis reveals 43% antisense transcription in 1182 transcripts in mouse muscle

artículo científico publicado en 2006

Correlation between PARP-1 immunoreactivity and cytomorphological features of parthanatos, a specific cellular death in breast cancer cells

artículo científico publicado en 2013

Correlation of histopathological and biochemical appraisal of anthracyclin-induced myocardium damage.

artículo científico publicado en 2002

Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor

artículo científico publicado en 2008

Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade

artículo científico publicado en 2005

Doxorubicin delivery enhanced by electroporation to gastrointestinal adenocarcinoma cells with P-gp overexpression

artículo científico publicado en 2014

E-cadherin and fibronectin expressions have no prognostic role in stage II ductal breast cancer

scientific article published on 01 July 2005

ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up.

artículo científico publicado en 2013

Effect of diallyl disulfide and garlic oil on different human astrocytoma cell lines

artículo científico publicado en 2020

Effect of melatonin on cytotoxic effects of daunorubicin on myocardium and on transplantable Morris hepatoma in rats

artículo científico publicado en 2002

Elevated BUBR1 expression is associated with poor survival in early breast cancer patients: 15-year follow-up analysis

artículo científico publicado en 2013

Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin's lymphomas

artículo científico publicado en 2011

Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance.

artículo científico publicado en 2005

Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients

artículo científico publicado en 2013

Elevated nuclear YB1 expression is associated with poor survival of patients with early breast cancer.

artículo científico publicado en 2012

Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patients.

artículo científico publicado en 2012

Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells.

artículo científico publicado en 2009

Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival

artículo científico publicado en 2011

Evaluation of transfection effectiveness using fluorescein-labelled oligonucleotides and various liposomes.

artículo científico publicado en 2003

Expression of aminopeptidase N/CD13 in human ovarian cancers

scientific article published on 01 September 2006

Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients.

artículo científico publicado en 2007

Expression of metallothionein (MT) and gluthatione s-transferase pi (SGTP) in the bone marrow of patients with myeloproliferative disorders (MPD).

artículo científico publicado en 2004

Expression of metallothionein in synovial sarcoma cells.

artículo científico publicado en 2002

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

artículo científico publicado en 2006

Highly expressed genes are associated with inverse antisense transcription in mouse

scientific article published on 01 August 2007

Identification of consensus genes and key regulatory elements in 5-fluorouracil resistance in gastric and colon cancer

artículo científico publicado en 2007

Immunocytochemical evaluation of metallothionein (MT) expression in myoepithelial cells of ductal mammary carcinoma and its relation to survival time: analysis of 7-year course of the disease.

artículo científico publicado en 2002

In vitro analysis of the relationships between metallothionein expression and cisplatin sensitivity of non-small cellular lung cancer cells

artículo científico publicado en 2013

Increase in cyclooxygenase-2 (COX-2) expression in keratinocytes and dermal fibroblasts in photoaged skin

artículo científico publicado en 2014

Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD).

artículo científico publicado en 2003

Increased expression of vascular endothelial growth factor in bone marrow of multiple myeloma patients

artículo científico publicado en 2003

Influence of exogenous melatonin on doxorubicin-evoked effects in myocardium and in transplantable Morris hepatoma in rats

artículo científico publicado en 2003

Influence of tamoxifen on cisplatin-sensitivity and estrogen receptors expression in ovarian carcinoma cell lines

artículo científico publicado en 2010

Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents

scientific article published on 01 July 2006

Lack of relationship between metallothionein (MT) expression and proliferation exponents in cells of primary ductal breast cancer of G2 grade of differentiation

artículo científico publicado en 2004

Localisation of exogenous surfactants in cell membranes in the air-blood barrier: rat model.

artículo científico publicado en 2003

Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients

artículo científico publicado en 2011

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor.

artículo científico publicado en 2012

Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates

artículo científico publicado en 2006

Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication

artículo científico publicado en 2003

Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers.

artículo científico publicado en 2006

Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.

artículo científico publicado en 2010

Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome.

artículo científico publicado en 2007

Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node‑negative early breast cancer: 15-year follow-up.

artículo científico publicado en 2014

Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.

artículo científico publicado en 2007

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer

artículo científico publicado en 2013

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer

artículo científico publicado en 2010

Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer

artículo científico publicado en 2008

Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomas

artículo científico publicado en 2009

Prediction of the response to chemotherapy in ovarian cancers

artículo científico publicado en 2006

Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas

artículo científico

Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine

artículo científico publicado en 2003

Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course.

artículo científico publicado en 2003

Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease

scientific article published on 01 January 2001

Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients

artículo científico publicado en 2005

Quercetin inhibits proliferation and increases sensitivity of ovarian cancer cells to cisplatin and paclitaxel.

artículo científico publicado en 2013

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells

artículo científico publicado en 2006

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

artículo científico publicado en 2005

Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.

artículo científico publicado en 2005

Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.

artículo científico publicado en 2002

Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat.

artículo científico publicado en 2002

Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers.

artículo científico publicado en 2005

Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers

artículo científico publicado en 2004

Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers

scientific article published on 01 January 2006

Suitability of tissue prints for immunocytochemical diagnosis of mammary cancer

artículo científico publicado en 2001

Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients.

artículo científico publicado en 2007

The analysis of estrogen and pregesterone receptors in leiomyomas cell in different phases of menstrual cycle

scientific article published on 01 April 2000

The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel.

artículo científico publicado en 2003

The photodynamic effect of far-red range phthalocyanines (AlPc and Pc green) supported by electropermeabilization in human gastric adenocarcinoma cells of sensitive and resistant type

artículo científico publicado en 2014

Topoisomerase 1A, HER/2neu and Ki67 expression in paired primary and relapse ovarian cancer tissue samples.

artículo científico publicado en 2006

Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue.

artículo científico publicado en 2006

Unfavourable prognostic significance of S100P expression in ovarian cancers

scientific article published on 31 May 2007

YB-1 as a potential target in cancer therapy

artículo científico publicado en 2008

YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells

artículo científico publicado en 2013

[Analysis of BCRP expression in breast cancer patients]

scientific article published on 01 September 2012

[Classical and novel molecular prognostic factors in ovarian cancers]

artículo científico publicado en 2005

[Selective estrogen receptor modulators]

artículo científico publicado en 2004

[The relationship of the expression of proliferetron--related antigens Ki67 and PCNA in the cells of ductal breast cancer with the differentiation grade]

artículo científico publicado en 2005

Lista de obras de Pawel Surowiak

A comprehensive overview of targeted therapy in metastatic renal cell carcinoma

ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome

ABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome

Analysis of estrogen receptor (ER) and estrogen-dependent pS2 protein expression in cells of mammary ductal carcinoma

Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients

Analysis of the expression of estrogen and progesteron receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle.

Application of Microarrays for the Prediction of Therapy Response in Breast Cancer

Application of biotinylated tyramine to amplify reactions with horseradish peroxidase labelling

Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up.

Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients

Betulinic acid exhibits stronger cytotoxic activity on the normal melanocyte NHEM-neo cell line than on drug-resistant and drug-sensitive MeWo melanoma cell lines.

Biomarkers for systemic therapy in ovarian cancer

CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases

CD46 Expression is an unfavorable prognostic factor in breast cancer cases

CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients

COX-2 expression pattern is related to ovarian cancer differentiation and prognosis, but is not consistent with new model of pathogenesis

Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines.

Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells.

Computational analysis reveals 43% antisense transcription in 1182 transcripts in mouse muscle

Correlation between PARP-1 immunoreactivity and cytomorphological features of parthanatos, a specific cellular death in breast cancer cells

Correlation of histopathological and biochemical appraisal of anthracyclin-induced myocardium damage.

Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor

Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade

Doxorubicin delivery enhanced by electroporation to gastrointestinal adenocarcinoma cells with P-gp overexpression

E-cadherin and fibronectin expressions have no prognostic role in stage II ductal breast cancer

ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up.

Effect of diallyl disulfide and garlic oil on different human astrocytoma cell lines

Effect of melatonin on cytotoxic effects of daunorubicin on myocardium and on transplantable Morris hepatoma in rats

Elevated BUBR1 expression is associated with poor survival in early breast cancer patients: 15-year follow-up analysis

Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin's lymphomas

Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance.

Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients

Elevated nuclear YB1 expression is associated with poor survival of patients with early breast cancer.

Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patients.

Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells.

Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival

Evaluation of transfection effectiveness using fluorescein-labelled oligonucleotides and various liposomes.

Expression of aminopeptidase N/CD13 in human ovarian cancers

Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients.

Expression of metallothionein (MT) and gluthatione s-transferase pi (SGTP) in the bone marrow of patients with myeloproliferative disorders (MPD).

Expression of metallothionein in synovial sarcoma cells.

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Highly expressed genes are associated with inverse antisense transcription in mouse

Identification of consensus genes and key regulatory elements in 5-fluorouracil resistance in gastric and colon cancer

Immunocytochemical evaluation of metallothionein (MT) expression in myoepithelial cells of ductal mammary carcinoma and its relation to survival time: analysis of 7-year course of the disease.

In vitro analysis of the relationships between metallothionein expression and cisplatin sensitivity of non-small cellular lung cancer cells

Increase in cyclooxygenase-2 (COX-2) expression in keratinocytes and dermal fibroblasts in photoaged skin

Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD).

Increased expression of vascular endothelial growth factor in bone marrow of multiple myeloma patients

Influence of exogenous melatonin on doxorubicin-evoked effects in myocardium and in transplantable Morris hepatoma in rats

Influence of tamoxifen on cisplatin-sensitivity and estrogen receptors expression in ovarian carcinoma cell lines

Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents

Lack of relationship between metallothionein (MT) expression and proliferation exponents in cells of primary ductal breast cancer of G2 grade of differentiation

Localisation of exogenous surfactants in cell membranes in the air-blood barrier: rat model.

Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor.

Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates

Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication

Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers.

Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.

Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome.

Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node‑negative early breast cancer: 15-year follow-up.

Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer

Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer

Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomas

Prediction of the response to chemotherapy in ovarian cancers

Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas

Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine

Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course.

Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease

Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients

Quercetin inhibits proliferation and increases sensitivity of ovarian cancer cells to cisplatin and paclitaxel.

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.

Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.

Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat.